Cardiac Implantable Electronic Device (CIED) Research Study
- Conditions
- TachycardiaArrhythmias, CardiacBradycardia
- Interventions
- Device: cardiac implantable electronic devices (CIEDs)
- Registration Number
- NCT05061862
- Lead Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Brief Summary
The study is designed to collect data on Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details, and/or patient characteristics to support development of future CIED products and procedures.
- Detailed Description
This is a data collection, non-randomized, multi-center study. The study will consist of different cohorts with each cohort being independent from another cohort. Each cohort may have a distinct objective, cohort-specific subject population, procedures, and assessments. The study will follow subjects receiving routine care, who meet all of the inclusion criteria and none of the exclusion criteria.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- Subject is at least 18 years of age.
- Subject is willing and able to provide written informed consent.
- Subject is willing and able to complete the study procedures and visits for the duration of data collection requirements
- Subject is unwilling or unable to comply with study procedures as defined in the protocol.
- Subject with a medical condition that precludes the patient from participation in the opinion of the investigator.
- Subject is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CIED Indicated Subjects cardiac implantable electronic devices (CIEDs) Subjects indicated to receive a cardiac implantable electronic devices (CIEDs)
- Primary Outcome Measures
Name Time Method Product Development 3 years Characterize Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details and/or patient characteristics to support development of future CIED products and procedures.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
UZ Leuven - Campus Gasthuisberg
π§πͺLeuven, Belgium
The Cardiac & Vascular Institute
πΊπΈGainesville, Florida, United States
Georgia Arrhythmia Consultants
πΊπΈMacon, Georgia, United States
Oregon Health & Science University Hospital
πΊπΈPortland, Oregon, United States
Lancaster General Hospital
πΊπΈLancaster, Pennsylvania, United States
Allegheny General Hospital
πΊπΈPittsburgh, Pennsylvania, United States
University of Virginia Medical Center
πΊπΈCharlottesville, Virginia, United States
Inova Fairfax Hospital
πΊπΈFalls Church, Virginia, United States
Sentara Norfolk General Hospital
πΊπΈNorfolk, Virginia, United States